|
From drug-experienced persons. The history of treatment with antiretroviral drugs was available for all patients but was not revealed to the testing laboratories. Phenotypic drug resistance analysis. Specimens were tested for resistance to 12 to drugs by the Antivirogram and PhenoSense HIV assays. The drugs included six nucleoside RT inhibitors NRTIs; zidovudine, lamivudine, zalcitabine, stavudine, didanosine, and abacavir ; , one nucleotide RT inhibitor NtRTI; adefovir ; , three non-NRTIs NNRTIs; nevirapine, delavirdine, and efavirenz ; , and five PR inhibitors PIs; indinavir, nelfinavir, saquinavir, ritonavir, and amprenavir ; . The Antivirogram assay was performed at Virco by the recombinant virus assay approach described by Hertogs et al. 5 ; , with modifications, as described elsewhere R. J. Powells, K. Hertogs, S. Kemp, S. Bloor, K. Acker, J. Hansen, W. Beukeleer, C. Roelant, B. Larder, and P. Stoffels, Abstr. 2nd Int. Workshop HIV Drug Resist. Treatment Strategies, abstr. 51, 1998 ; . Briefly, the PR- and RTcoding sequences were amplified from patient-derived viral RNA with HIV-1specific primers. After homologous recombination of amplicons into a proviral clone from which the coding sequences for PR and RT were deleted, the resulting recombinant viruses were harvested, titrated, and used for in vitro testing of susceptibility to antiretroviral drugs. The IC50s for the test recombinant virus were compared to those for a drug-susceptible reference HIV-1 strain strain HXB-2 ; . Viruses were categorized as sensitive or having reduced susceptibility on the basis of established drug-specific cutoff values. These values were based on the natural variations in the phenotypic susceptibilities of approximately 1, 000 HIV-1 isolates from treatment-nai patients. Values considered evidence of ve reduced susceptibility were increases in the IC50s of more than 2.5-fold for saquinavir and amprenavir; 3-fold for stavudine, abacavir, and indinavir; 3.5-fold for didanosine, zalcitabine, and ritonavir; 4-fold for zidovudine, adefovir, and nelfinavir; 4.5-fold for lamivudine; 6-fold for efavirenz; 8-fold for nevirapine; and 10-fold for delavirdine. Data were also analyzed by use of the previously used assay cutoff value fourfold change in the IC50 ; 5 ; . The PhenoSense HIV assay was performed at ViroLogic Inc. as described by Petropoulos et al. 16 ; . Briefly, HIV-1 PR- and RT-coding sequences were amplified by reverse transcription-PCR and cloned into a recombinant HIV vector containing a luciferase reporter gene. The constructs were transformed into Escherichia coli to produce resistance test vectors RTVs ; . Viral stocks were prepared by cotransfecting cultures of cells of the 293 cell line with RTV DNA and an expression vector that produces the envelope proteins from an amphotropic murine leukemia virus. Pseudotyped virus particles were harvested from the transfected cell cultures and used to infect fresh 293 cells. Drug susceptibility was measured by adding PIs to transfected cells or RTIs to infected 293 cells; the levels of virus replication were measured on the basis of luciferase activity. Since RTVs are replication defective, luciferase activity is measured following a single round of replication. The IC50s were compared to those for a drug-susceptible reference HIV-1 strain strain NL4-3 ; . Increases in the IC50s of more than 2.5-fold were considered evidence of reduced susceptibility.
Murine earwax removal system
New York State Dept. of Health.
49. Zen, K., Babbin, B. A., Liu, Y., Whelan, J. B., Nusrat, A., Parkos, C. A. 2004 ; JAM-C is a component of desmosomes and a ligand for CD11b CD18-mediated neutrophil transepithelial migration. Mol. Biol. Cell 15, 3926 3937. Schenkel, A. R., Mamdouh, Z., Chen, X., Liebman, R. M., Muller, W. A. 2002 ; CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3, 143150. 51. Feng, D., Nagy, J. A., Pyne, K., Dvorak, H. F., Dvorak, A. M. 1998 ; Neutrophils emigrate from venules by a transendothelial cell pathway in response to fMLP. J. Exp. Med. 187, 903915. 52. Berlin, C., Bargatze, R. F., Campbell, J. J., von Andrian, U. H., Szabo, M. C., Hasslen, S. R., Nelson, R. D., Berg, E. L., Erlandsen, S. L., Butcher, E. C. 1995 ; 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80, 413 422. Alon, R., Kassner, P. D., Carr, M. W., Finger, E. B., Hemler, M. E., Springer, T. A. 1995 ; The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128, 12431253. 54. Salas, A., Shimaoka, M., Kogan, A. N., Harwood, C., von Andrian, U. H., Springer, T. A. 2004 ; Rolling adhesion through an extended conformation of integrin L 2 and relation to I and I-like domain interaction. Immunity 20, 393 406. DeGrendele, H. C., Estess, P., Picker, L. J., Siegelman, M. H. 1996 ; CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183, 1119 1130. Salmi, M., Jalkanen, S. 2001 ; VAP-1: an adhesin and an enzyme. Trends Immunol. 22, 211216. 57. Mizgerd, J. P., Meek, B. B., Kutkoski, G. J., Bullard, D. C., Beaudet, A. L., Doerschuk, C. M. 1996 ; Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs. J. Exp. Med. 184, 639 645. Wong, J., Johnston, B., Lee, S. S., Bullard, D. C., Smith, C. W., Beaudet, A. L., Kubes, P. 1997 ; A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J. Clin. Invest. 99, 27822790. 59. Kuijper, P. H., Gallardo Torres, H. I., van der Linden, J. A., Lammers, J. W., Sixma, J. J., Koenderman, L., Zwaginga, J. J. 1996 ; Plateletdependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 87, 32713281. 60. Weber, C., Springer, T. A. 1997 ; Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to IIb 3 and stimulated by platelet-activating factor. J. Clin. Invest. 100, 20852093. 61. Kirchhofer, D., Riederer, M. A., Baumgartner, H. R. 1997 ; Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. Blood 89, 1270 1278. Kubes, P. 2002 ; The complexities of leukocyte recruitment. Semin. Immunol. 14, 6572. 63. Languino, L. R., Plescia, J., Duperray, A., Brian, A. A., Plow, E. F., Geltosky, J. E., Altieri, D. C. 1993 ; Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73, 14231434. 64. Simon, D. I., Chen, Z., Xu, H., Li, C. Q., Dong, J., McIntire, L. V., Ballantyne, C. M., Zhang, L., Furman, M. I., Berndt, M. C., Lopez, J. A. 2000 ; Platelet glycoprotein Ib is a counterreceptor for the leukocyte integrin Mac-1 CD11b CD18 ; . J. Exp. Med. 192, 193204. 65. Santoso, S., Sachs, U. J., Kroll, H., Linder, M., Ruf, A., Preissner, K. T., Chavakis, T. 2002 ; The junctional adhesion molecule 3 JAM-3 ; on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196, 679 691. Cunningham, S. A., Rodriguez, J. M., Arrate, M. P., Tran, T. M., Brock, T. A. 2002 ; JAM2 interacts with 4 1. Facilitation by JAM3. J. Biol. Chem. 277, 27589 27592. Taooka, Y., Chen, J., Yednock, T., Sheppard, D. 1999 ; The integrin 9 1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J. Cell Biol. 145, 413 420. Herwald, H., Cramer, H., Morgelin, M., Russell, W., Sollenberg, U., Norrby-Teglund, A., Flodgaard, H., Lindbom, L., Bjorck, L. 2004 ; M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116, 367379. 69. Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, G., Parsons, J. T., Horwitz, A. R. 2003 ; Cell migration: integrating signals from front to back. Science 302, 1704 1709. Imhof, B. A., Aurrand-Lions, M. 2004 ; Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4, 432 444.
Murine eye products
Panels, dividing partitions not of metal. Office furniture sets, office furniture, tables, desks, desk case assemblies, cabinets, riser shelves, furniture for computer equipment.
10 days of treatment on percent mortality in murine cryptococcal meningitis. The control group received 0.3% Noble agar. P 0.05 when combined-treatment group compared with groups given fluconazole and flucytosine individually and control group. P 0.05 comparing single-drug regimen groups with control group. There were 10 animals per group.
Samples of recent movers W achter and M egbolu gbe, 1992 ; . Recently, a num ber of researchers Tipple and W illis, 1991; Korboe, 1992; Amole et al., 1993 ; have sought to establish that tenure choice in W est African cities may transcend the two modal prototy pes of renters and ow ners. They identify the existence of rent-free consum ers or family-hou sers Tipple and W illis, 1991 ; with family rights to housing either via inheritance or the favour of a living owner. Indeed, Korboe 1992 ; estimates that about 25 per cent of all house holds are likely to fall within this category. W hile it would have been preferable to undertake separate analysis for such house holds, this has not been possible, as our data set made no distinction betw een owner-occupiers and familyhousers. W hile this groupin g increases the proportion of owner-occupier households in our sample, it should not adversely affect our and muse.
Designed specifically to provide protection, long life and renewed vitality to vinyl sign and awning surfaces. It penetrates the surface and bonds with the vinyl to return it to a nearly new, original appearance. Best results if used on clean existing vinyl surfaces. Available in 1 gallon and 5 gallon containers.
Al-Shammri SA, Guberman A, Hsu E. Neuroblastoma and foetal exposure to phenytoin in a child without dysmorphic features. Can J Neurol Sci 1992; 19: 2435. Allen RW, Ogden B, Bentley FL, Jung AL. Foetal hydantoin syndrome, neuroblastoma and hemorrhagic disease in a neonate. J Med Assoc 1980; 244: 14645. Anthony JJ. Malignant lymphoma associated with hydantoin drugs. Arch Neurol 1970; 22: 4504. Annegers JF, Kurland LT, Hauser WA. Brain tumors in children exposed to barbiturates. J Natl Cancer Inst 1979; 63: 3. Aymard JP, Lederlin P, Witz F, Colomb JN, Faure G, Guerci O, Herbeuval R. Multiple myeloma after phenytoin therapy. Scand J Haematol 1981; 26: 3302. Baker AF, Dorr RT. Drug interactions with the taxanes: clinical implications. Cancer Treat Rev 2001; 27: 22133. Baker DK, Relling MV, Pui CH, Christensen ML, Evans WE, Rodman JH. Increased teniposide clearance with concomitant anticonvulsant therapy. J Clin Oncol 1992; 10: 3115. Bardana EJ, Gabourel JD, Davies GH, Craig S. Effect of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement and antinuclear antibody. J Med 1983; 74: 28996. Becker FF. Tumor phenotype and susceptibility to progression as an expression of subpopulations of initiated murine cells. Cancer Res 1985; 45: 76873. Bell GS, Sander JW. The epidemiology of epilepsy: the size of the problem. Seizure 2001; 10: 30614. Bell GS, Gaitatzis A, Johnson AL, Sander JW. Predictive value of death certification in the case ascertainment of epilepsy. J Neurol Neurosurg Psychiatry 2004; 75: 17568. Benedetti MS. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol 2000; 14: 30119. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs. Epilepsy Research 2004; 61: 148. Blaheta RA, Cinatl J Jr. Anti-tumour mechanisms of valproate: a novel role for an old drug. Med Res Rev 2002; 22: 492511. Blaheta R, Hernaiz Driever P, Michaelis M, Cinatl J. The evolving anticancer drug Valproic acid: Insights into the mechanism and clinical studies--an update. Curr Med Chem. In press 2004. Brodtkorb E, Nakken KO, Steinlein OK. No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy. Epilepsy Res 2003; 56: 2058. Chhabra RS, Bucher JR, Haseman JK, Elwell MR, Kurtz PJ, Carlton BD. Comparative carcinogenicity of 5, 5-diphenylhydantoin with or without perinatal exposure in rats and mice. Fundam Appl Toxicol 1993; 21: 17486. Chang TK, Chen G, Waxman DJ. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism. J Pharmacol Exp Ther 1995; 274: 2705. Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol 1998; 16: 218894. Chang SM, Kuhn J, Wen P, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, Cloughesy T, De Angelis L, Razier J, Hess K, Dancey J, Prados MD. Phase I pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. Invest New Drugs 2004; 22: 42735. Chen G, Manji MK, Hawver DB, Wright CB, Potter WZ. Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 1994; 63: 23614. Chen G, Masana MI, Manji HK. Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo. Bipolar Disord 2000; 2: 21736 and mycostatin.
Murine earigate cleansing system
ARRE-1 region, the NF-IL2B region and the CD28RR Fig. 4B, lanes 3 6 ; as previously described 28 ; . HMGA1a footprints are also detected at the NF- B site and CD28RE when the opposite strand is analyzed Fig. 4C, lanes 25 ; . When HMGA1a was titrated onto IL-2 nucleosomal DNA, footprints were observed specifically at the ARRE-1, NF-IL2B regions, CD28RR and the NF- B site Fig. 4, B, lanes 8 11, and C, lanes 9 11, refer to lines ; . At these regions, the presence of HMGA1a also resulted in the reappearance of specific DNase I hypersensitive bands Fig. 4, B, lane 8, and C, lane 9, refer to dots ; seen in naked DNA and may represent local disruption of the nucleosome: DNA contacts at the specific regions where HMGA1a binds. However, HMGA1 proteins did not appear to alter the rotational setting of the nucleosome nor did they promote the binding of transcription factors such as c-Rel or AP-1 to the nucleosome-assembled IL-2 promoter data not shown ; . In summary, all of the transcription factors tested, with the exception of HMGA1, were occluded from binding to the nucleosome-assembled IL-2 promoter. HMGA1 bound to the nucleo.
Logical relationship between serum copper and atherosclerotic disease 7076 ; and papers citing an epidemiologic relationship between Cp levels and atherosclerotic disease Table 3; Refs. 7783 ; . One group controlled for the inflammatory component by adjusting for such things as protein C levels, and found that a substantial risk from elevated Cp remained 84 ; . We found one paper failing to find a relationship between serum copper and coronary heart disease, at least in patients with moderate coronary heart disease 85 ; , and another paper that observed no relationship between Cp and coronary heart disease when patients with inflammation were excluded 86 ; . Elevated levels of Cp and copper have been found in type I and type II diabetes mellitus Table 3 ; , which are risk factors for cardiovascular disease 87 ; . Diabetic patients with vascular complications have higher plasma copper levels than diabetic patients without complications or normal controls 87 ; . Patients with the ``metabolic syndrome'' patients having in common risk factors such as obesity, hypertension, glucose intolerance, and dyslipidemia ; also have elevated Cp levels 88 ; . Some animal model work has been done on copper and atherosclerosis. First, it is clear that severe copper deficiency damages blood vessels, perhaps as a result of deficiencies of copper-dependent enzymes, such as lysyl oxidase, important in collagen cross-linking, and copper zinc superoxide dismutase SOD ; , important in oxidant protection. For example, Dalle Lucca et al. 89 ; find increased neointima thickening in the copper-deficient rat carotid artery and attribute it to the lower SOD levels they also find. Similarly, Saari et al. 90 ; review all the harmful effects on the cardiovascular system of severe copper deficiency and also and mysoline.
Killing murine norovirus
The priority for management of the prawn fisheries is to ensure that the fishery is sustainable so that future generations may benefit from exploitation of the resource. Commensurate with this priority are a number of more specific biological, economic, environmental and social objectives that have been developed by the Prawn FMC to complement the broad directives of section 20 of the Fisheries Act 1982. McDonald 1998 ; provides an outline of the Management plan for the Spencer Gulf Prawn Fishery. The primary management objectives for the Spencer Gulf fishery are: To maintain the biomass within historical levels and eliminate risk of recruitment decline due to over-fishing; To ensure harvesting procedures are directed towards optimising size at capture; To maintain and enhance the profitability of the fishery by optimising prawn size, market timing, minimising the costs of fishing and the administrative costs of managing the fishery; and To minimise bycatch and trawl impact to the benthos through development of more effective and efficient gear and harvesting strategies.
10. Bielicki, J., Hopwood, J.J., Wilson, P.J. and Anson, D.S. 1993 ; Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem. J., 289, 241246. 11. Bielicki, J., Fuller, M., Guo, X.H., Morris, C.P., Hopwood, J.J. and Anson, D.S. 1995 ; Expression, purification and characterisation of recombinant human Biochem. J., 311, 333339. 12. Bielicki, J., Hopwood, J.J., Melville, E.L. and Anson, D.S. 1998 ; Recombinant human sulphamidase: expression, amplification, purification and characterization. Biochem. J., 329, 145150. 13. Unger, E.G., Durrant, J., Anson, D.S. and Hopwood, J.J. 1994 ; Recombinant -L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts. Biochem. J., 304, 4349. 14. Kakkis, E.D., Matynia, A., Jonas, A.J. and Neufeld, E.F. 1994 ; Overexpression of the human lysosomal enzyme -L-iduronidase in Chinese hamster ovary cells. Protein Express. Purif., 5, 225232. 15. Fuller, M., Van der Ploeg, A., Reuser, A.J.J., Anson, D.S. and Hopwood, J.J. 1995 ; Isolation and characterisation of a recombinant, precursor form of lysosomal acid alpha-glucosidase. Eur. J. Biochem., 234, 903909. 16. Weber, B., Blanch, L., Clements, P.R., Scott, H.S. and Hopwood, J.J. 1996 ; Cloning and expression of the gene involved in Sanfilippo B syndrome mucopolysaccharidosis III B ; . Hum. Mol. Genet., 5, 771777. 17. Van Hove, J.L.K., Yang, H.W., Wu, J.Y., Brady, R.O. and Chen, Y.T. 1996 ; High-level production of recombinant human lysosomal acid -glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc. Natl Acad. Sci. USA, 93, 6570. 18. Litjens, T., Bielicki, J., Anson, D.S., Friderici, K., Jones, M.Z. and Hopwood, J.J. 1997 ; Expression, purification and characterization of recombinant caprine N-acetylglucosamine-6-sulphatase. Biochem. J., 327, 8994. 19. Salminen, A. and Marjomaki, V. 1985 ; Phosphomannosyl receptors of lysosomal enzymes in cardiac and skeletal muscles of young and old mice. Comp. Biochem. Physiol., 82, 259262. 20. Taylor, J.E., Scott, C.D. and Baxter, R.C. 1985 ; Comparison of receptors for insulin-like growth factor II from various rat tissues. J. Endocrinol., 115, 3541. 21. Oude Elferink, R.P.J., Brouwer-Kelder, E.M., Surya, I., Strijland, A., Kroos, M., Reuser, A.J.J. and Tager, J.M. 1984 ; Isolation and characterization of a precursor form of lysosomal -glucosidase from human urine. Eur. J. Biochem., 139, 489495. 22. Van der Ploeg, A.T., Kroos, M., van Dongen, J.M., Visser, W.J., Bolhuis, P.A., Loonen, M.C. and Reuser, A.J.J. 1987 ; Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid alpha-glucosidase. J. Neurol. Sci., 79, 327336. 23. Van der Ploeg, A.T., Loonen, M.C.B., Bolhuis, P.A., Busch, H.M.F., Reuser, A.J.J. and Galjaard, H. 1988 ; Receptor-mediated uptake of acid -glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle. Pediatr. Res., 24, 9094. 24. Kikuchi, T., Yang, H.W., Pennybacker, M., Ichihara, N., Mizutani, M., Van Hove, J.L.K. and Chen, Y.T. 1998 ; Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail. J. Clin. Invest., 101, 827833. 25. Lee, S.H. and De Boer, H.A. 1994 ; Production of biomedical proteins in the milk of transgenic dairy cows: the state of the art. J. Control. Release, 29, 213221. 26. Bijvoet, A.G.A., Kroos, M.A., Pieper, F.R., de Boer, H.A., Reuser, A.J.J., van der Ploeg, A.T. and Verbeet, M.P. 1996 ; Expression of cDNA-encoded human acid -glucosidase in milk of transgenic mice. Biochim. Biophys. Acta, 1308, 9396. 27. Bijvoet, A.G.A., Van de Kamp, E.H.M., Kroos, M.A., Ding, J.H., Yang, B.Z., Visser, P., Bakker, C.E., Verbeet, M.P., Oostra, B., Reuser, A.J.J. and Van der Ploeg, A.T. 1998 ; Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum. Mol. Genet., 7, 5362. 28. Reuser, A.J., Kroos, M.A., Ponne, N.J., Wolterman, R.A., Loonen, M.C., Busch, H.F., Visser, W.J. and Bolhuis, P.A. 1984 ; Uptake and stability of human and bovine acid alpha-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patients. Exp. Cell Res., 155, 178189. 29. Kaplan, A., Achord, D.T. and Sly, W.S. 1977 ; Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc. Natl Acad. Sci. USA, 74, 20262030. 30. Houdebine, L.M. 1994 ; Production of pharmaceutical proteins from transgenic animals. J. Biotechnol., 34, 269287. 31. Sands, M.S., Vogler, C., Kyle, J.W., Grubb, J.H., Levy, B., Galvin, N., Sly, W.S. and Birkenmeier, E.H. 1994 ; Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J. Clin. Invest., 93, 23242331. 32. Shull, R.M., Kakkis, E.D., McEntee, M.F., Kania, S.A., Jonas, A.J. and Neufeld, E.F. 1994 ; Enzyme replacement in a canine model of Hurler syndrome. Proc. Natl Acad. Sci. USA, 91, 1293712941. 33. Enomaa, N., Danos, O., Peltonen, L. and Jalanko, A. 1995 ; Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer. Hum. Gene Ther., 6, 723731. 34. Kakkis, E.D., McEntee, M.F., Schmidtchen, A., Neufeld, E.F., Ward, D.A., Gompf, R.E., Kania, S., Bedollia, C., Chien, S.L. and Shull, R.M. 1996 ; Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I. Biochem. Mol. Med., 58, 156167. 35. Crawley, A.C., Brooks, D.A., Muller, V.J., Petersen, B.A., Isaac, E.L., Bielicki, J., King, B.M., Boulter, C.D., Moore, A.J., Fazzalari, N.L., Anson, D.S., Byers, S. and Hopwood, J.J. 1996 ; Enzyme replacement therapy in a feline model of MaroteauxLamy syndrome. J. Clin. Invest., 97, 18641873. 36. Ioannou, Y.A., Zeidner, K.M., Friedman, B. and Desnick, R.J. 1996 ; Fabry disease: enzyme replacement therapy in -galactosidase A deficient mice. Am. J. Hum. Genet., 59, A15. 37. Wall, R.J., Martin, B.M., Stubblefield, B., Eliason, W., Pursel, V.G., Henninghausen, L., Ginns, E.I. and Sidransky, E. 1994 ; The production of human glucocerebrosidase in the milk of lactating mammals. Am. J. Hum. Genet., 55, A179. 38. Brinster, R.L., Allen, J.M., Behringer, R.R., Gelinas, R.E. and Palmiter, R.D. 1988 ; Introns increase transcriptional efficiency in transgenic mice. Proc. Natl Acad. Sci. USA, 85, 836840. 39. Palmiter, R.D., Norstedt, G., Gelinas, R.E., Hammer, R.E. and Brinster, R.I. 1991 ; Heterologous introns can enhance expression of transgenes in mice. Proc. Natl Acad. Sci. USA, 88, 478482. 40. Raben, N., Nichols, R.C., Martiniuk, F. and Plotz, P.H. 1996 ; A model of mRNA splicing in adult lysosomal storage disease glycogenosis type II ; . Hum. Mol. Genet., 5, 9951000. 41. Rijnkels, M., Kooiman, P.M., Platenburg, G.J., Van Dixhoorn, M., Nuijens, J.H., De Boer, H.A. and Pieper, F.R. 1995 ; High-level expression of the bovine s1-casein in milk of transgenic mice. Transgenic Res., 6, 110. 42. Molenaar, A.J., Davis, S.R. and Wilkins, R.J. 1992 ; Expression of -lactalbumin, S1-casein, and lactoferrin genes is heterogeneous in sheep and cattle mammary tissue. J. Histochem. Cytochem., 40, 611618. 43. Faerman, A., Barash, I., Puzis, R., Nathan, M., Hurwitz, D.R. and Shani, M. 1995 ; Dramatic heterogeneity of transgene expression in the mammary gland of lactating mice: a model system to study the synthetic activity of mammary epithelial cells. J. Histochem. Cytochem., 43, 461470. 44. Dobie, K.W., Lee, M., Fantes, J.A., Graham, E., Clark, A.J., Springbett, A., Lathe, R. and McClenaghan, M. 1996 ; Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus. Proc. Natl Acad. Sci. USA, 93, 66596664. 45. Wisselaar, H.A., Kroos, M.A., Hermans, M.M.P., van Beeumen, J. and Reuser, A.J.J. 1993 ; Structural and functional changes of lysosomal acid -glucosidase during intracellular transport and maturation. J. Biol. Chem., 268, 22232231. 46. Reuser, A.J.J., Kroos, M., Oude Elferink, R.P.J. and Tager, J.M. 1985 ; Defects in synthesis, phosphorylation, and maturation of acid -glucosidase in glycogenosis type II. J. Biol. Chem., 260, 83368341. 47. Willemsen, R., Van der Ploeg, A.T., Busch, H.F.M., Zondervan, P.E., Van Noorden, C.J.F. and Reuser, A.J.J. 1993 ; Synthesis and in situ localization of lysosomal -glucosidase in muscle of an unusual variant of glycogen storage disease type II. Ultrastruct. Pathol., 17, 515527. 48. Hoefsloot, L.H., Hoogeveen-Westerveld, M., Reuser, A.J.J. and Oostra, B.A. 1990 ; Characterization of the human lysosomal alpha-glucosidase gene. Biochem. J., 272, 493497. 49. Platenburg, G.J., Kootwijk, E.P.A., Kooiman, P.M., Woloshuk, S.L., Nuijens, J.H., Krimpenfort, P.J.A., Pieper, F.R., de Boer, H.A. and Strijker, R. 1994 ; Expression of human lactoferrin in milk of transgenic mice. Transgenic Res., 3, 99108. 50. Konings, R.N., Luiten, R.G. and Peeters, B.P. 1986 ; Mike, a chimeric filamentous phage designed for the separate production of either DNA strand of pKUN vector plasmids by F + cells. Gene, 46, 269276. 51. Hogan, B., Beddington, R., Costantini, F. and Lacy, E. 1994 ; Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 52. Reuser, A.J.J., Koster, J.F., Hoogeveen, A. and Galjaard, H. 1978 ; Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am. J. Hum. Genet., 30, 132143 and nadolol.
Murine earigater
Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells.
Ideally, ships should seek to minimize reliance on chemical pest control procedures and the adverse health effects of pesticides. Integrated pest management IPM ; is a comprehensive approach to pest control and prevention that considers all available strategies, including mechanical, cultural, biological, and chemical techniques. Nonchemical pest controls, such as good sanitation practices and the elimination of pest harborages and access, should be implemented prior to use of any chemical control measures. Pesticides Pesticide applicators should be trained and certified when Environmental Protection Agency EPA ; restricted-use pesticides are being applied. A log and or file should be maintained to indicate the type, quantity, and location applied for any pesticides used onboard. Procedures should be consistent with the Federal Insecticide, Fungicide and Rodenticide Act, EPA and Occupational Safety and Health OSHA ; standards. Pesticides are hazardous materials and a Material Safety Data Sheet MSDS ; should be maintained on hand for any pesticides available for use. Follow all precautions and recommendations of the manufacturer as described in the MSDS. The container labeling will also provide important safety information. All chemicals that are used to control vectors should be kept in their original containers, properly labeled and securely stored away from food stores and cargo ; . Rodents Rats on a ship are a health menace and a nuisance. They cause extensive damage to cargo and food, and rat droppings contain organisms which produce diseases. Rats carry fleas which may transmit plague and murine typhus. Because of these dangers, ships heavily infested with rats must be fumigated, and fumigation is a laborious, expensive, and dangerous procedure. It can be avoided through adequate rat-control measures. A deratization exemption certificate provided after an inspection that demonstrated the ship was rodent-free is required for some ports. The ship's agent should be able to make arrangements for an inspection to receive this certificate. Despite reasonable precautions by the ship's personnel and port authorities, some rats may get aboard. However, infestation can be avoided. The following are guidelines to prevent and control rodents onboard ship: when moored, use approved and properly installed rat guards on all shipshore lines to prevent rodents from getting aboard via these lines frequently inspect for signs of rat life trails or runs marked by dirt or droppings ; and take quick action if evidence is found rat proofing the ship, thus "building out" the rats by elimination of their living places or harborages keeping all food protected and avoiding accumulation of food scraps and garbage, thus "starving out" the rodents and nafcillin.
Clinicopathologic study of dextran sulfate sodium experimental murine colitis
Hyde Park Properties Inc., is a partnership between the Zentil and Benedetto families, with over forty years of experience in the development of commercial, industrial and residential properties in the Greater Toronto Area. In addition, to a portfolio of industrial properties, The group currently manages and operates 500 rental units in the Toronto area and has built over 5, 000 apartment units. The company is seeking to expand its residential portfolio and will shortly begin construction of 965 units in Leaside. Hyde Park is actively exploring the potential of new rental construction on other sites in its land holdings in the GTA.
Gests a much earlier involvement of angiogenesis. The presence of both patterns of vascular development was evident as early as 4 wk gestation in embryonic lung and also in fetal lungs at later gestation. These data suggest that vasculogenesis and angiogenesis occur concomitantly in human lung vascular development. Our histologic analyses revealed marked similarities between vascular development in human and murine embryonic fetal lungs as shown by de Mello and coworkers 25 ; using vascular casting and scanning EM techniques. Maeda and colleagues 26 ; recently demonstrated the two patterns of vascular development in human fetal lungs from the pseudoglandular stage onwards. Our data, from much earlier in gestation, is in agreement with their findings. Both studies used the same technique of double immunolabeling of CD34 and SM -actin. Insulin-like growth factors IGF-I II ; play a crucial role in cell proliferation and differentiation 5 ; during embryogenesis. Our IGF-I IIIGF-IR immunolocalization studies are consistent with IGFs acting as either autocrine and or paracrine mediators of human fetal lung development. The colocalization of CD34-positive cells and IGF-I in embryonic and fetal lungs of 412 wk gestation, but not in the 19-wk fetal lung canalicular stage ; , is intriguing. We speculate that IGF-I plays a role in both proliferation and maintaining the population of ECs in early stages of lung vascular development, but not in the midgestation of lung development. The observation of intense expression mRNA and protein ; of both IGF-I and IGF-II, and of the IGF-I receptor, as early as 4 wk ECs lining the primary vascular plexuses of human embryonic lungs is significant and highly suggestive of a role for this growth factor in early vascular development. This possibility was supported by studies in which we were able to demonstrate a dramatic reduction in the number of endothelial cells when 12-wk human fetal lung explants were treated with a neutralizing antibody to the IGF-IR. Both TUNEL and transmission electron microscopy analyses of these lung explants revealed significantly increased levels of apoptosis in mesenchymal cells. The apoptosis of mesenchymal cells was not limited to EC only. However, the quantitative analyses demonstrated a significant reduction of CD34-immunoreactive cells in the mesenchyme of antiIGF-IRexposed lung explants. This indirectly suggests that a significant number of apoptotic cells were EC. This is consistent with the transmission electron microscopy findings that EC lining the developing vessels and the mesenchymal cells both showed evidence of apoptosis. Furthermore, the presence of large gaps in the mesenchyme of lung explants that were exposed to antiIGF-IR is consistent with a significant number of mesenchymal cells undergoing apoptosis. We conducted an experiment to prove that the neutralizing antibody we used for human fetal lung explants did have an effect on IGF-IR signaling. Our initial approach to immunoprecipitate IGF-IR followed by receptor phosphorylation on lung explants failed to demonstrate discernible bands. This could be due to the fact that only minute numbers of IGF-IR were present in lung explants that were treated in a serum-free medium for 5 d. We then used an indirect approach using exogenous and naloxone.
Murine orth
All study personnel must be familiar with the schedule of visits to ensure that required data are collected and that future visits are scheduled within appropriate time windows. The necessity for timely examinations should be stressed during participant orientation and during continuing education and murine.
Murine cells definition
Macrolide structure, peer review global warming, health physics employment, aspirations and molluscum contagiosum groin. Arteriosclerosis symptoms more tests_diagnosis, dystocia and augmentation of labor, carcinogenic static and cancer cluster san diego or haploid and diploid cells.
Murine skin cells
Umrine, murie, murnie, mugine, murihe, murinr, mueine, mjrine, mhrine, jurine, murune, urine, murkne, murime, muribe, muriine, mutine, mrine, murinne, murinf.
Side effects of Murine
Murine earwax removal system, murine eye products, murine earigate cleansing system, killing murine norovirus and murine earigater. Clinicopathologic study of dextran sulfate sodium experimental murine colitis, murine orth, murine cells definition and murine skin cells or side effects of murine.
|
